Vancouver, Canada

Timothy Scott Daynard

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy Scott Daynard

Introduction

Timothy Scott Daynard is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific biological pathways. With a total of 16 patents to his name, Daynard's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents is the invention of substituted tetrahydropyrido[3',2':4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors. This patent describes carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK). The pharmaceutical compositions comprising these derivatives are intended for treating diseases associated with RSK activity. Another notable patent involves TOFA analogs useful in treating dermatological disorders or conditions. This invention focuses on analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their application in treating conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin.

Career Highlights

Throughout his career, Timothy Daynard has worked with notable companies, including Dermira, Inc. and QLT Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research and development.

Collaborations

Daynard has collaborated with several professionals in his field, including Zaihui Zhang and Shisen Wang. These collaborations have likely enhanced the scope and impact of his inventions.

Conclusion

Timothy Scott Daynard's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing medical challenges. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…